Test Price
1,800 AED✅ Home Collection Available
Immune Complex Detection by C1q Binding Assay in UAE | 1,800 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – available daily from 8 AM to 11 PM. Serum must be separated and frozen at −20 °C immediately after draw to preserve C1q binding integrity.
Clinical Guidance: Post-test telephonic result interpretation by a DHA-licensed physician.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | Quantitative C1q ELISA | Qualitative / Photometric |
| Methodology | Enzyme Immunoassay (ELISA) | PEG Precipitation or RIA |
| Turnaround | 2–3 Weeks (batch processing; sample required by 7th of month) | Variable |
Physician Insight & Safety Protocols
“As a DHA-licensed General Practitioner, I recommend this assay as a complementary tool for evaluating immune-complex–mediated pathology. Results must be interpreted alongside the full clinical picture, including specific autoantibody panels and inflammatory markers. Patients should never alter or discontinue prescribed therapies based solely on this test result.” – Dr. Ajay Singh, DHA Registration ID: 36234132.
Advisory – Medication Continuation
Do not stop or adjust any prescribed immunosuppressive or disease-modifying medication without consulting your treating physician. Abrupt changes can lead to disease flares or adverse outcomes.
Exclusion Criteria & ER Red Flags
- Active severe infection or sepsis – may confound immune complex measurement.
- Known immediate hypersensitivity to any component of the collection or assay system.
- Inability to provide an adequate serum specimen under strict cold-chain conditions.
- ER Red Flags: Acute onset of joint swelling, facial butterfly rash, chest pain, or sudden dyspnea – seek emergency medical attention immediately.
Patient FAQ & Clinical Guidance
1. What is the C1q Binding Immune Complex test used for?
This quantitative ELISA measures circulating immune complexes in serum to help diagnose and monitor autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Elevated levels indicate active immune-complex–mediated pathology that requires clinical correlation.
2. Why must the sample be frozen immediately and shipped on dry ice?
Immune complexes are labile at room temperature. Rapid serum separation and freezing at −20 °C (or below) preserves the structural integrity of C1q-binding sites, ensuring accurate quantitative results. Our cold-chain logistics team coordinates pickup within 30 minutes of draw to maintain stability.
3. How should I interpret a positive result?
A positive result indicates elevated circulating immune complexes, which may reflect autoimmune activity. However, a DHA-licensed physician must integrate this finding with clinical symptoms, other autoantibody tests (e.g., anti-dsDNA, RF, anti-CCP), and inflammatory markers before making diagnostic or therapeutic decisions.
4. Can I take this test if I am on immunosuppressive therapy?
Yes, but the results must be interpreted in the context of your current treatment. Immunosuppressants can lower immune complex levels. Never modify your medication regimen without explicit guidance from your prescribing physician.
UAE Regulatory & Data Privacy Adherence
- Data Protection: All patient information is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Health ICT Security: Our laboratory information systems adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Medical Liability: Clinical safety and patient consent follow the standards set by Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Laboratory operations are licensed by DHA and MOHAP.
- Consent: A duly filled Send Out Consent Form (Form 35) is mandatory prior to sample collection.
Clinical & Logistical Metadata
| Test Name | Immune Complex Detection by C1q Binding Assay (ELISA) |
| Price (AED) | 1,800 |
| Turnaround Time | 2–3 Weeks (batch processing; sample required by 7th of month) |
| Sample Type / Matrix | Serum (Peripheral Blood) – Cold-Chain Required; VIP Mobile Phlebotomy & Temperature-Controlled Home Collection available daily 8 AM – 11 PM |
| Methodology Used | Quantitative Enzyme Immunoassay (ELISA) |
| ICD-10-CM Code | M32.9 (Systemic lupus erythematosus, unspecified) |
| LOINC Code | 13975-4 (C1q binding [Units/volume] in Serum) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians